Bank Of New York Mellon Corp Next Cure, Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$9.81 - $13.88 $1,746 - $2,470	-178 Reduced 0.32%	56,010 $560,000
Q4 2020 Feb 09, 2021	SELL	$9.47 - $12.43 $29,347 - $38,520	-3,099 Reduced 5.23%	56,188 $612,000
Q3 2020 Nov 12, 2020	SELL	$8.15 - $21.17 $13,822 - $35,904	-1,696 Reduced 2.78%	59,287 $521,000
Q2 2020 Aug 12, 2020	BUY	$21.19 - $40.2 $235,865 - $447,466	11,131 Added 22.33%	60,983 $1.31 Million
Q1 2020 May 06, 2020	BUY	$32.32 - $58.37 $183,965 - $332,242	5,692 Added 12.89%	49,852 $1.85 Million
Q4 2019 Feb 14, 2020	BUY	$25.0 - $92.22 $733,400 - $2.71 Million	29,336 Added 197.9%	44,160 $2.49 Million
Q3 2019 Nov 07, 2019	BUY	$15.73 - $41.6 $233,181 - $616,678	14,824 New	14,824 $457,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.